Pharvaris expects to ask the U.S. Food and Drug Administration to approve deucrictibant as an on-demand treatment for…
Lila Levinson, PhD
Lila is a Science Writer at BioNews. She completed her PhD in neuroscience at the University of Washington, where she studied how the natural flexibility of the human brain can be used to promote recovery after injury. Previously, she has written about science for The Dallas Morning News and the University of Washington Computational Neuroscience Center. She enjoys exploring the Pacific Northwest and spending time with her cat, Fibonacci.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Lila Levinson, PhD
Recognizing a problem early and treatment can help avoid life-threatening complications when swelling of the larynx, or voice box, caused…
A new scoring system may help emergency physicians diagnose hereditary angioedema (HAE), potentially allowing patients to receive treatment faster,…
Donidalorsen, a preventive therapy being developed to reduce the frequency of swelling attacks for people with hereditary angioedema…
Most allergist-immunologists who treat people with hereditary angioedema (HAE) think genetic testing may be useful in diagnosing irregular cases,…
A man in his 60s who developed severe angioedema after the use of an ACE, or angiotensin-converting enzyme, inhibitor…
People from underrepresented racial and ethnic groups who have hereditary angioedema (HAE) continue facing barriers to diagnosis and effective…
Kaken Pharmaceutical obtained the rights to commercialize sebetralstat, an on-demand treatment for hereditary angioedema (HAE), in Japan…